Radioprotective effect of sulfasalazine on mouse bone marrow chromosomes

Mutagenesis

Volumn 23, Issue 4, 2008, Pages 285-292

  Mantena, Sudheer K ^a   Unnikrishnan, M K ^a   Uma Devi, P ^b  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

^b Jawaharlal Nehru Cancer Hospital & Research Centre Bhopal   (India)

Author keywords

[No Author keywords available]

Indexed keywords

SALAZOSULFAPYRIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CHROMOSOME ABERRATION; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GAMMA RADIATION; IN VIVO STUDY; LD 50; MALE; MOUSE; NONHUMAN; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIATION PROTECTION;

ANIMALS; BONE MARROW CELLS; CHROMOSOMES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; FEMALE; GAMMA RAYS; MALE; MICE; RADIATION-PROTECTIVE AGENTS; SULFASALAZINE; TIME FACTORS;

MUS;

EID: 46349089106     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/gen005     Document Type: Article

References (68)

1. Monig, H., Messerschmidt, O. and Streffer, C. (1990) Chemical radioprotection in mammals and in man. In Scherer, E., Streffer, C. and Trott, K. R. (eds), Radiation Exposure and Occupational Risks. Springer-Verlag, Berlin, Germany, pp. 97-143.
2. Uma Devi, P. (1998) Normal tissue protection in cancer therapy: progress and prospects. Acta Oncol., 37, 247-252.
3. Riis, P., Anthonsien, P., Wulff, H. R., Folkenborg, O., Bonnevie, O. and Binder, V. (1973) The prophylactic effect of salazosulphapyridine in ulcerative colitis during long-term treatment: a double-blind trial on patients asymptomatic for one year. Scand. J. Gastroenterol., 8, 71-74.
4. Svartz, N. (1941) Ett nytt sulfonamidpreparat. Forelopande meddelande. Nord. Med., 9, 544.
5. Hoult, J. R. S. (1986) Pharmacological and biochemical actions of sulphasalazine. Drugs, 32, 18-26.
6. Azad Khan, A. K., Piris, J. and Truelove, S. C. (1977) An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet, 2, 892-895.
7. Klotz, U., Maier, K., Fischer, C. and Heinkel, K. (1980) Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease. N. Engl. J. Med., 303, 1499-1502.
8. Sutherland, L. R., May, G. R. and Shaffer, E. A. (1993) Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann. Intern. Med., 118, 540-549.
9. Pruzanski, W., Stefanski, E., Vadas, P. and Ramamurty, N. S. (1997) Inhibition of extracellular release of proinflammatory secretory phospholipase A2 by sulfasalazine. Biochem. Pharmacol., 53, 1901-1907.
10. Carlin, G., Djursater, R. and Smedegard, G. (1989) Inhibitory effects of sulfasalazine and related compounds on superoxide production by human polymorphonuclear leukocytes. Pharmacol. Toxicol., 65, 121-127.
11. Rhodes, J. M., Bartholomew, T. C. and Jewell, D. P. (1981) Inhibition of leucocyte motility by drugs used in ulcerative colitis. Gut, 22, 642-647.
12. Rubinstein, A., Das, K. M., Melamed, J. and Murphy, R. A. (1978) Comparative analysis of systemic immunological parameters in ulcerative colitis and idiopathic proctitis: effect of sulfasalazine in vivo and in vitro. Clin. Exp. Immunol., 33, 217-224.
13. Sheldon, P. J., Webb, C. and Grindulis, K. A. (1988) Effect of sulphasalazine and its metabolites on mitogen induced transformation of lymphocytes-clues to its clinical action? Br. J. Rheumatol., 27, 344-349.
14. Fujiwara, M., Mitsui, K. and Yamamoto, I. (1990) Inhibition of proliferative responses and interleukin 2 production by salazosulfapyridine and its metabolites. Jpn. J. Pharmacol., 54, 121-132.
15. Gaginella, T. S. and Walsh, R. E. (1992) Sulfasalazine: multiplicity of action. Dig. Dis. Sci., 37, 801-812.
16. Gionchetti, P., Guarnieri, C., Campieri, M., Belluzzi, A., Brignola, C., Iannoe, P., Miglioli, M. and Barbara, L. (1991) Scavenger effects of sulfasalazine, 5-aminosalicylic acid, olsalazine on superoxide radical generation. Dig. Dis. Sci., 36, 174-178.
17. Miyachi, Y., Yoshioka, A., Imamura, S. and Niwa, Y. (1987) Effect of sulfasalazine and its metabolites on the generation of reactive oxygen species. Gut, 28, 190-195.
18. Pronai, L., Yukinobu, I., Lang, I. and Feher, J. (1992) The oxygen centered radical scavenging activity of sulfasalazine and its metabolites. A direct protection of bowel. Acta Physiol. Hung., 80, 317-323.
19. Rauch, K. and Weilland, H. (1972) Behandlung der radiogenen kolitis mit salisilazosulfapyridin (azusulfidine). Strahlentherapie, 143, 660-663.
20. Kilic, D., Ozenirler, S., Egenhan, I. and Dursun, A. (2001) Sulfasalazine decreases acute gastrointestinal complications due to pelvic radiotherapy. Ann. Pharmacother., 35, 806-810.
21. Kilic, D., Ozenirler, S., Egenhan, I. and Dursun, A. (2000) Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of sulphasalazine in preventing acute gastrointestinal complications due to radiotherapy. Radiother. Oncol., 57, 125-129.
22. Lee, Y. S., Kang, S. K., Kim, T. H., Myong, N. H. and Jang, J. J. (1998) Species, strain and sex differences in susceptibility to gamma radiation combined with diethylnitrosamine. Anticancer Res., 18, 1105-1109.
23. Calabrese, E. J. and Baldwin, L. A. (2000) The effects of gamma rays on longevity. Biogerontology, 1, 309-319.
24. Ghosh, M. N. (1984) Fundamentals of Experimental Pharmacology. 2nd edn. Scientific Book Agency, Calcutta, India, 153-157.
25. Geigy, J. R. (1956) Documents Geigy Scientific Tables. 5th edn. J. Board & Co. Ltd., Basle, UK, pp. 26-48.
26. Uma Devi, P., Bisht, K. S. and Vinitha, M. (1998) A comparative study of radioprotection by ocimum flavonoids and synthetic aminothiol protectors in the mouse. Br. J. Radiol., 71, 782-784.
27. Savage, J. R. K. (1976) Classification and relationships of induced chromosomal structural changes. J. Med. Genet., 12, 103-122.
28. Bender, M. A., Awa, A. A., Brooks, A. L., Evans, H. J., Groer, P. G., Littlefield, L. G., Pereira, C., Preston, R. J. and Wachholz, B. W. (1988) Current status of cytogenetic procedures to detect and quantify previous exposures to radiation. Mutat. Res., 196, 103- 159.
29. Schmid, W. (1973) Chemical mutagen testing on in vivo somatic cells. Agents Actions, 3, 77-85.
30. Schmid, W. (1979) The micronucleus test. Mutat. Res., 31, 9-15.
31. Wijewickreme, A. N., Krejpcio, Z. and Kitts, D. D. (1999) Hydroxyl scavenging activity of glucose, fructose and ribose-lysine model Maillard products. J. Food Sci., 64, 457-461.
32. Cole, R. J., Tylor, N., Cole, J. and Arlett, C. F. (1981) Short-term tests for transplacentally active carcinogens. I. Micronucleus formation in fetal and maternal mouse erythroblasts. Mutat. Res., 80, 141-157.
33. Jagetia, G. C. and Ganapathi, N. G. (1991) Treatment of mice with a herbal preparation (Liv. 52) reduces the frequency of radiation-induced chromosome damage in bone marrow. Mutat. Res., 253, 123-126.
34. Jagetia, G. C., Venkatesha, V. A. and Reddy, T. K. (2003) Naringin, a citrus flavonone, protects against radiation-induced chromosome damage in mouse bone marrow. Mutagenesis, 18, 337-343.
35. Carrano, A. V. and Heddle, J. A. (1973) The fate of chromosome aberrations. J. Theor. Biol., 38, 289-304.
36. Sasaki, H. (2004) Lethal sectoring, genomic instability, and delayed division delay in HeLa S3 cells surviving alpha- or X-irradiation. J. Radiat. Res., 45, 497-508.
37. Fenech, M. (2007) Cytokinesis-block micronucleus cytome assay. Nat. Protoc., 2, 1084-1104.
38. Hofer, M., Mazur, L., Pospisil, M., Weiterova, L. and Znojil, V. (2000) Radioprotective action of extracellular adenosine on bone marrow cells in mice exposed to gamma rays as assayed by the micronucleus test. Radiat. Res., 154, 217-221.
39. Yuhas, J. M. and Storer, J. B. (1969) Chemoprotection against three modes of radiation death. Int. J. Radiat. Biol., 15, 233-237.
40. Uma Devi, P. and Prasanna, P. G. S. (1990) Radioprotective effect of combinations of WR-2721 and mercaptopropionylglycine on mouse bone marrow chromosomes. Radiat. Res., 124, 165-170.
41. Gupta, R. and Uma Devi, P. (1986) Protection of mouse chromosomes against whole-body gamma irradiation by SH-compounds. Br. J. Radiol., 59, 625-627.
42. Thomas, B. and Uma Devi, P. (1987) Chromosome protection by WR-2721 and MPG-single and combination treatments. Strahlenther Onkol., 163, 807-810.
43. Ganasoundari, A., Uma Devi, P. and Rao, B. S. S. (1998) Enhancement of bone marrow radioprotection and reduction of WR-2721 toxicity by Ocimum sanctum. Mutat. Res., 397, 303-312.
44. Jagetia, G. C. and Aruna, R. (1997) The herbal preparation abana protects against radiation-induced micronuclei in mouse bone marrow. Mutat. Res., 393, 157-163.
45. Chaubey, R. C., Bhilwade, H. N., Joshi, B. N. and Chauhan, P. S. (1993) Studies on the migration of micronucleated erythrocytes from bone marrow to the peripheral blood in irradiated Swiss mice. Int. J. Radiat. Biol., 63, 239-245.
46. Sudheer Kumar, M., Unnikrishnan, M. K. and Uma Devi, P. (2003) Effect of 5-aminosalicylic acid on radiation-induced micronuclei in mouse bone marrow. Mutat. Res., 527, 7-14.
47. Grzelinska, E., Bartkowiak, A., Bartosz, G. and Leyko, W. (1982) Effect of •OH scavengers on radiation damage to the erythrocyte membrane. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med., 41, 473-481.
48. Joshi, R., Kumar, S., Unnikrishnan, M. and Mukherjee, T. (2005) Free radical scavenging reactions of sulfasalazine, 5-aminosalicylic acid and sulfapyridine: mechanistic aspects and antioxidant activity. Free Radic. Res., 39, 1163-1172.
49. Bishop, J. B., Witt, K. L., Gulati, D. K. and MacGregor, J. T. (1990) Evaluation of the mutagenicity of the anti-inflammatory drug salicylazosulfapyridine (SASP). Mutagenesis, 5, 549-554.
50. Iatropoulos, M. J., Williams, G. M., Abdo, K. M., Kari, F. W. and Hart, R. W. (1997) Mechanistic studies on genotoxicity and carcinogenicity of salicylazosulfapyridine an anti-inflammatory medicine. Exp. Toxicol. Pathol., 49, 15-28.
51. Uma Devi, P., Nagarathnam, A. and Rao, B. S. S. (2000) DNA damage and repair. In Introduction to Radiation Biology. Churchill Livingstone Pvt. Ltd., New Delhi, India, pp. 52-64.
52. Sasaki, M. S. and Matsubara, S. (1977) Free radical scavenging in protection of human lymphocytes against chromosome aberration formation by gamma-ray irradiation. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med., 32, 439-445.
53. Roots, R. and Okada, S. (1972) Protection of DNA molecules of cultured mammalian cells from radiation-induced single-strand scissions by various alcohols and SH compounds. Int J. Radiat. Biol. Relat. Stud. Phys. Chem. Med., 21, 329-342.
54. Okada, S., Nakamura, N. and Sasaki, K. (1983) Radioprotection of intracellular genetic material. In Nygaard, O. F. and Simic, M. G. (eds), Radioprotection and Anticarcinogens. Academic Press, New York, pp. 339-356.
55. Shimoi, K., Masuda, S., Shen, B., Furugori, M. and Kinae, N. (1996) Radiation protection effect of antioxidative plant flavonoids in mice. Mutat. Res., 350, 153-161.
56. Abraham, S. K., Sarma, L. and Kesavan, P. C. (1993) Protective effects of chlorogenic acid, curcumin and β-carotene against c-radiation-induced in vivo chromosomal damage. Mutat. Res., 303, 109-112.
57. Sarma, L. and Kesavan, P. C. (1993) Protective effects of vitamin C and E against γ-ray-induced chromosomal damage in mouse. Int. J. Radiat. Biol., 63, 759-764.
58. Umegaki, K., Ikegami, S., Inoue, K., Ichikawa, T., Kobayashi, S., Soeno, N. and Tomebachi, K. (1994) Beta-carotene prevents X-ray induction of micronuclei in human lymphocytes. Am. J. Clin. Nutr., 59, 409-412.
59. O'Neill, P. and Fielden, E. M. (1993) Primary free radical processes in DNA. In Lett, J. T. and Sinclair, W. K. (eds), Advances in Radiation Biology. Academic Press, New York, pp. 53-120.
60. Uma Devi, P., Ganasoundari, A., Rao, B. S. S. and Srinivasan, K. K. (1999) In vivo radioprotection by ocimum flavonoids: survival of mice. Radiat. Res., 151, 74-78.
61. Maisin, J. R., Albert, C. and Henry, A. (1993) Reduction of short-term radiation lethality by biological response modifiers given alone or in association with other chemical protectors. Radiat. Res., 135, 332-337.
62. Michalowski, A. D. (1994) On radiation damage to normal tissue and treatment. Acta Oncol., 33, 139-157.
63. Satyamitra, M., Uma Devi, P., Murase, H. and Kagiya, V. T. (2003) In vivo postirradiation protection by a vitamin E analog, alpha-TMG. Radiat. Res., 160, 655-661.
64. Farooqi, Z. and Kesavan, P. C. (1992) Radioprotection by caffeine pre- and post-treatment in the bone marrow chromosomes of mice given whole-body c-irradiation. Mutat. Res., 269, 225-230.
65. Gout, P. W., Buckley, A. R., Simms, C. R. and Bruchovsky, N. (2001) Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)-cystine transporter: a new action for an old drug. Leukemia, 15, 1633-1640.
66. Chung, W. J., Lyons, S. A., Nelson, G. M., Hamza, H., Gladson, C. L., Gillespie, G. Y. and Sontheimer, H. (2005) Inhibition of cystine uptake disrupts the growth of primary brain tumors. J. Neurosci., 25, 7101-7110.
67. Doxsee, D. W., Gout, P. W., Kurita, T. et al. (2007) Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy. Prostate, 67, 162-171.
68. Fischer-Nielsen, A., Poulsen, H. E. and Loft, S. (1992) 8-Hydroxydeoxyguanosine in vitro: effects of glutathione, ascorbate and 5-aminosalicylic acid. Free Radic. Biol. Med., 13, 121-126.